Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Eli Lilly Stock Was a Winner Today

TheMotleyFool

0 0

A hopeful report about a potential blockbuster drug currently in development and news of an expansion of manufacturing capability helped push Eli Lilly (NYSE: LLY) stock skyward on Tuesday. Shares of the massive U.S. pharmaceutical company closed the day more than 2% higher in value, on a session when the S&P 500 index landed slightly in the red.

Reuters published an article speculating that orforglipron, Eli Lilly's next-generation obesity drug currently in development, could earn Food and Drug Administration (FDA) approval by the end of this year.

Image source: Getty Images.

Source Fool.com

Like: 0

LLY

Share